OSUR OraSure Technologies Inc.

OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call  Wednesday, November 4, 2020, 5:00 p.m. ET

OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call  Wednesday, November 4, 2020, 5:00 p.m. ET

BETHLEHEM, Pa., Oct. 21, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 third quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 4, 2020. 

November 4, 2020 Schedule
 
4:01 p.m. ET2020 third quarter financial results press release will be distributed.
  
4:50 p.m. ETTo participate in the conference call, dial 844-831-3030 (Domestic) or 315-625-6887 (International) and reference Conference ID # 9459222
  
5:00 p.m. ETConference call and simultaneous Webcast begins.

The conference call will also be available via webcast, and may be accessed on the Investor Relations page of OraSure’s website, . Please click on the webcast link and follow the prompts for registration and access, ten minutes prior to the call.

If you are unable to participate, a replay of the call will be archived on OraSure’s website shortly after the call has ended and will be available for 14 days. A replay of the call can also be accessed until midnight, November 18, 2020 by dialing (855) 859-2056 (Domestic) or (404) 537-3406 (International) and entering the Conference ID # 9459222.

COMPANY CONTACT: Sam Martin, Argot Partners. 212-602-1902, or .

EN
21/10/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OraSure Technologies Inc.

 PRESS RELEASE

OraSure Announces Third Quarter 2025 Financial Results

OraSure Announces Third Quarter 2025 Financial Results BETHLEHEM, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended September 30, 2025. “In Q3 we delivered $27.1 million of revenue. While some of our customers continue to experience elevated levels of uncertainty related to funding for public health programs and research, we remain confident in our opportunities to return to growth in 2026, driven by divers...

 PRESS RELEASE

OraSure to Announce Third Quarter 2025 Financial Results and Host Earn...

OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November 5, 2025. A webcast of the conference call will be available on the investor relations page of OraSure’s website at . Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webca...

 PRESS RELEASE

OraSure Technologies Appoints Steven K. Boyd to its Board of Directors

OraSure Technologies Appoints Steven K. Boyd to its Board of Directors Seasoned Investor with Deep Experience in the Healthcare and Medical Device Industries Brings Valuable Capital Markets Expertise and Investor Perspective  OraSure Board Has Added Three New Independent Directors in the Past Three Years Mara Aspinall to Step Down from the Board; Jack Kenny Appointed as Chair of the Board BETHLEHEM, Pa., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announc...

 PRESS RELEASE

OraSure Announces Second Quarter 2025 Financial Results

OraSure Announces Second Quarter 2025 Financial Results BETHLEHEM, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended June 30, 2025. “Our Q2 results were consistent with our expectations. We are making significant progress on our initiatives to expand our product portfolio, including launching our novel blood collection device for proteomic research in July. We are also staying closely aligned with our custome...

 PRESS RELEASE

OraSure Appoints Anne Messing as Chief Commercial Officer

OraSure Appoints Anne Messing as Chief Commercial Officer BETHLEHEM, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that Anne Messing has joined OTI as Chief Commercial Officer. Ms. Messing brings more than 25 years of commercial leadership experience across the healthcare industry, including in life sciences, diagnostics, and clinical laboratory services, with a proven track record of driving growth, building high-performing sales teams, and tra...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch